Ed planning versus 3-dimensional planning for accelerated partial breast radiotherapy resource links provided by nlm: genetics home reference related topics: breast cancer medlineplus related topics: breast cancer cancer u. viagra coupon free where to buy viagra online safely how much does viagra cost in nz S. buy viagra online cheap generic viagra viagra coupon free Fda resources further study details as provided by rocky mountain cancer centers: primary outcome measures: prevalence of breast pain after accelerated partial breast radiotherapy (apbi) [ time frame: 5 years ] [ designated as safety issue: yes ]assessment by both treating investigators and by subjective patient outcomes questionnaires filled out at each follow-up visit prevalence of chest wall pain after accelerated partial breast radiotherapy (apbi) [ time frame: 2-5 years ] [ designated as safety issue: yes ]assessment by both treating investigators and by subjective patient outcomes questionnaires filled out at each follow-up visit secondary outcome measures: dosimetric comparison [ time frame: 5-10 days ] [ designated as safety issue: yes ]comparison of treatment plans and actual doses received between comparable patients treated with 3d-crt and imrt with regard to treatment target and normal tissue acute skin reactions [ time frame: 6 months ] [ designated as safety issue: yes ]radiation-induced dermatitis cosmetic outcomes after apbi [ time frame: 2-5 years ] [ designated as safety issue: no ]assesed by both treating investigators and subjective patient questionnaires filled out at each follow-up visit ipsilateral breast tumor recurrence [ time frame: 5-15 years ] [ designated as safety issue: no ]track occurrence and patterns of local treatment failures or new primaries within the treated breast (efficacy outcome measure) cause specific survival [ time frame: 5-15 years ] [ designated as safety issue: no ]track survival status and the specific cause(s) of death if applicable for study participants (efficacy outcome measure) disease free survival [ time frame: 5-15 years ] [ designated as safety issue: no ]track breast-cancer free survival status of study participants (efficacy outcome measure) overall survival [ time frame: 5-15 years ] [ designated as safety issue: no ]track the overall survival status of all study participants (efficacy outcome measure) estimated enrollment: 660 study start date: july 2009 estimated study completion date: july 2028 estimated primary completion date: july 2018 (final data collection date for primary outcome measure) arms assigned interventions experimental: imrt intensity modulated radiotherapy, 38. buy generic viagra online viagra without a doctor prescription 5 gy, 10 fractions over 5 days radiation: accelerated partial breast irradiation - imrt pl. viagra cost generic viagra use of viagra on women viagra coupon free
     
  Saltar intro